Carmignac Gestion’s Acceleron Pharma XLRN Stock Holding History

Carmignac Gestion’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-221,502	Closed	-$38.1M	–	142
2021 Q3	$38.1M	Sell	221,502 -236,764	-52%	-$31M	0.48%	44
2021 Q2	$57.5M	Buy	458,266 +265,209	+137%	+$33.4M	0.67%	42
2021 Q1	$26.2M	Buy	+193,057	New	+$24.9M	0.3%	54

Carmignac Gestion's XLRN Position: Q4 2021 in Review

Carmignac Gestion sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 221,502 shares — an estimated $38.1M sold.

Carmignac Gestion first reported a position in XLRN in Q1 2021 and held it in 3 quarters. The position peaked at $57.5M in Q2 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Carmignac Gestion reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Carmignac Gestion sold 221,502 Acceleron Pharma shares in Q4 2021, an estimated $38.1M.
Carmignac Gestion first reported a position in Acceleron Pharma in Q1 2021 and held it in 3 quarters.
Carmignac Gestion's Acceleron Pharma position peaked at $57.5M in Q2 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Carmignac Gestion's 13F filing for Q4 2021, filed 11 Feb 2022.